Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus
Main Authors: | Rania Zekry, Gamal A. Omran, Nashwa M. El-Gharbawy, Rehab H. Werida |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-43905-1 |
Similar Items
-
Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus
by: Rania Zekry, et al.
Published: (2023-04-01) -
The Discovery of Insulin-Regulated Aminopeptidase (IRAP) Inhibitors: A Literature Review
by: Dimitris Georgiadis, et al.
Published: (2020-09-01) -
Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Aryl Sulfonamides
by: Sudarsana Reddy Vanga, et al.
Published: (2018-04-01) -
Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Benzopyran-Based Inhibitors
by: Sudarsana Reddy Vanga, et al.
Published: (2021-04-01) -
Circulating IL-6, clusterin and irisin in obese subjects with different grades of obesity: association with insulin resistance and sexual dimorphism
by: Rehab H. Werida, et al.
Published: (2021-03-01)